Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Somatostatin analogues effectively manage ectopic ACTH syndrome when surgery isn't possible.

Frequent blood transfusions in beta thalassemia patients can lead to thyroid problems.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

GnRH treatment can reduce breast cancer cell invasion.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Early diagnosis and treatment of achalasia and hyperthyroidism improve patient outcomes.

A dog with a pituitary tumor developed tertiary hypothyroidism, improved with treatment, but was later euthanized due to neurological issues.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.